PRVA

Privia Health Group, Inc.

Healthcare · $2.5B market cap

Verdict

Share price

$20.30

close of Oct 3, 2026

Fair value

$40.81

Sticker Price

Payback Price

$16.32

buy price

Undervalued

PRVA is Undervalued: at $20.30 it trades 50% below its fair value of $40.81. Its buy price (Payback Price) is $16.32, 20% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow Growth. Reported earnings are shrinking, but free cash flow keeps growing, so we value it on cash flow.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-0.4% a year✗
Equity per share growth10.4% a year✓
Sales growth19.7% a year✓
Free cash flow growth41.1% a year✓
Return on invested capital2.3%✗

Follow PRVA

Get notified when it reaches its buy price of $16.32. Free.

Create a free account

Superinvestors

1 of the investors we track holds PRVA. Who we track

Insider activity

Since Jun 26, 2026: no open-market purchases, 10 sales worth $10.0M and 9 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Privia Health Group, Inc.

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works